@incollection{, 13D231C9417D91DDE1AE512D2A0BED3B , author={{Ek-UmaImkome} and {YunibhandJ} and {ChaiyawatW} and {NouanthongP} and {Thammasat University}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}1841523 } @incollection{b0, , title={{Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis}} , author={{ ChenC K } and { LinS KSham } and { PCBall } and { DLoh } and { EWHsiao } and { CC }} , journal={{Psychological medicine}} 33 8 , year={2003} } @incollection{b1, , title={{The impact of substance use disorders on clinical outcome in 643 patients with first episode psychosis}} , author={{ MLambert } and { PConus } and { DLubman } and { DWade } and { HYuen } and { SMoritz }} , journal={{Acta. Psychiatr. Scand}} 112 , year={2005} } @incollection{b2, , title={{Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis}} , author={{ BSchimmelmann } and { PConus } and { SCotton } and { SKupferschmid } and { PMc Gorry } and { MLambert }} , journal={{Eur. Psychiatry}} 27 , year={2012} } @incollection{b3, , title={{Stimulant psychosis: symptom profile and acute clinical course}} , author={{ DHarris } and { SLBatki }} , journal={{The American journal on addictions}} 9 1 , year={2000} } @incollection{b4, , title={{The prevalence of psychotic symptoms among methamphetamine users}} , author={{ RMcketin } and { JMclaren } and { DILubman } and { LHides }} , journal={{Addiction}} 101 10 , year={2006} } @book{b5, , title={{Psychotic symptoms in methamphetamine psychotic in-Persons. The international journal of neuro psychopharmacology}} , author={{ MSrisurapanont } and { RAli } and { JMarsden } and { ASunga } and { KWada } and { MMonteiro }} , year={2003} 6 } @incollection{b6, , title={{An exploratory analysis of neuro cognition methamphetamine-induced psychotic disorder and paranoid schizophrenia}} , author={{ EJacobs } and { DFujii } and { JSchiffman } and { IBello }} , journal={{Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology}} 21 2 , year={2008} } @book{b7, , title={{Predictors of Illicit Drug Use Among Prisoners. Substance use & misuse}} , author={{ TLRowell-Cunsolo } and { SampongS ABefus } and { MMukherjee } and { DVLarson } and { EL }} , year={2016} 51 } @incollection{b8, , title={{Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency}} , author={{ MJMarquine } and { JEIudicello } and { MorganE EBrown } and { GGLetendre } and { SL } and { EllisR J }} , journal={{Psychiatry research}} 215 1 , year={2014} } @incollection{b9, , title={{The relationship between cognitive dysfunction and coping abilities in schizophrenia}} , author={{ KEWilder-Willis } and { PKShear } and { SteffenJ JBorkin } and { J }} , journal={{Schizophrenia research}} 55 3 , year={2002} } @incollection{b10, , title={{Patient Factors that Impact upon Cognitive Behavioural Therapy for Psychosis: Therapists' Perspectives}} , author={{ SCurrell } and { TChristodoulides } and { JSiitarinen } and { RDudley }} , journal={{Behavioural and cognitive psychotherapy}} 44 4 , year={2016} } @incollection{b11, , title={{Presence and persistence of psychotic symptoms in cocaine-versus methamphetamine-dependent participants}} , author={{ JJMahoney } and { ADKalechstein } and { DeLaGarza } and { RNewton } and { TF }} , journal={{The American journal on addictions}} 17 2 , year={2008} } @incollection{b12, , title={{Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders}} , author={{ RMcketin } and { ALBaker } and { SDawe } and { AVoce } and { DILubman }} , journal={{Psychiatry research}} 251 , year={2017} } @book{b13, , title={{Brief Psychiatric Rating Scale (BPRS): Suanprung Psychiatric Hospital}} , author={{ P Kittirattanapiboon }} , year={2001} } @incollection{b14, , title={{A Path Analysis of Psychotic Symptoms Among Persons With Schizophrenia Using Methamphetamines}} , author={{ EImkome } and { JYunibhund } and { WChaiyawat }} 10.14456/vol16iss8pp%p , journal={{Walailak Journal of Science and Technology}} , year={2018} , publisher={WJST} } @incollection{b15, , title={{Medication adherence among persons with postacute myocardial infarction}} , author={{ AP Rapin } and { TYupin } and { Sureeporn }} , journal={{Songklanakarin J. Sci. Technol}} 38 , year={2016} } @book{b16, , title={{Development and validation of a Thai stressful life events rating scale for patients with a diagnosis of schizophrenic methamphetamine abuse}} , author={{ EImkome } and { JYunibhand } and { WChaiyawat }} , year={2017} } @incollection{b17, , title={{}} , journal={{Songklanakarin Journal Of Science & Technology}} 39 2 } @book{b18, , title={{Social support, self-care, and quality of life in cancer Persons receiving radiotherapy in Thailand}} , author={{ Hanucharurnkul }} , editor={Ph.D. Dissertation. Wayne State Uiversity} , year={1988} , address={Michigan, United States} } @incollection{b19, , title={{Testing psychometric properties of the Thai Social Dysfunction Rating Scale (TSDRS) in schizophrenic and methamphetamine abuse Persons}} , author={{ EImkome } and { JYunibhand } and { WChaiyawat }} 10.14456/jhr.2016.38 , journal={{J Health Res}} 2016 4 } @book{b20, , title={{Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study. Drug and alcohol review}} , author={{ RMcketin } and { AKothe } and { ALBaker } and { LeeN K } and { RossJLubman } and { DI }} , year={2018} 37 } @book{b21, , title={{Adherence to antipsychotic medications. The Journal of clinical psychiatry}} , author={{ DOPerkins }} , year={1999} 60 , note={Suppl 21} } @incollection{b22, , title={{Development and validation of the stressful life event questionnaire}} , author={{ HRoohafza } and { MRamezani } and { MSadeghi } and { MShahnam } and { BZolfagari } and { NSarafzadegan }} , journal={{International journal of public health}} 56 4 , year={2011} } @incollection{b23, , title={{Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study}} , author={{ RMcketin } and { DILubman } and { ALBaker } and { SDawe } and { RLAli }} , journal={{JAMA psychiatry}} 70 3 , year={2013} } @book{b24, , title={{Does the pattern of amphetamine use prior to incarceration predict later psychosis?--a longitudinal studyamphetamine users in the Swedish criminal justice system. Drug and alcohol dependence}} , author={{ EBRognli } and { AHakansson } and { JBerge } and { JGBramness }} , year={2014} 143 } @book{b25, , title={{Predicting the risk of psychosis onset: advances and prospects. Early intervention in psychiatry}} , author={{ EVStrobl } and { EackS MSwaminathan } and { VVisweswaran } and { S }} , year={2012} 6 } @book{b26, , title={{Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Persons with Neuroendocrine Tumors: A Pilot Study. Nursing researchpractice}} , author={{ THaugland } and { MVeenstra } and { MHVatn } and { AKWahl }} , year={2013. 2013} } @incollection{b27, , title={{An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity}} , author={{ ANFricks-Gleason } and { GermanC LHoonakker } and { AJFriend } and { DMGanesh } and { KKCarver } and { AS }} , journal={{Synapse}} 70 4 , year={2016} } @incollection{b28, , title={{Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters}} , author={{ JMKokoshka } and { VaughanR A } and { HansonG RFleckenstein } and { AE }} , journal={{European journal of pharmacology}} 361 2-3 , year={1998} } @incollection{b29, , title={{Methamphetamineinduced rapid and reversible changes in dopamine transporter function: an in vitro model}} , author={{ VSandoval } and { ELRiddle } and { YVUgarte } and { HansonG RFleckenstein } and { AE }} , journal={{The Journal of neuroscience : the official journal of the Society for Neuroscience}} 21 4 , year={2001} } @book{b30, , title={{The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis. Psychological medicine}} , author={{ DKimhy } and { GillK EBrucato } and { GVakhrusheva } and { JArndt } and { LGross } and { JJ }} , year={2016} 46 } @book{b31, , title={{Treatment of severe perinatal mood disorders on a specialized perinatal psychiatry inpatient unit. Archives of women's mental health}} , author={{ MCKimmel } and { SLara-Cinisomo } and { KMelvin } and { DiFlorio } and { ABrandon } and { AMeltzer-Brody } and { S }} , year={2016} 19 } @incollection{b32, , title={{Stimulant psychosis: systematic review}} , author={{ CCurran } and { NByrappa } and { AMc Bride }} , journal={{Br. J. Psychiatry}} 185 , year={2004} } @incollection{b33, , title={{An integrative perspective on the role of dopamine in schizophrenia}} , author={{ TMaia } and { MFrank }} , journal={{Biol. Psychiatry}} 81 , year={2017} } @incollection{b34, , title={{The role of endogenous sensitization in the patho-physiology of schizophrenia: implications from recent brain imaging studies}} , author={{ MLaruelle }} , journal={{Brain Res. Rev}} 31 , year={2000} } @incollection{b35, , title={{Schizophrenia, amphetamineinduced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization}} , author={{ MWang } and { LPei } and { PFletcher } and { SKapur } and { PSeeman } and { FLiu }} , journal={{Mol. Brain}} 3 , year={2010} } @incollection{b36, , title={{Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature}} , author={{ KCourtney } and { LRay }} , journal={{Drug Alcohol. Depend}} 143 , year={2014} }